MedTrace Logo

Local Anesthetic for Plateau Fractures

NCT06474949 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-26

No results posted yet for this study

Summary

Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay

Conditions

  • Tibial Plateau Fractures

Interventions

DRUG

Bupivacaine injection

Injection at end of Open Reduction Internal Fixation

OTHER

Saline

Injection at end of Open Reduction Internal Fixation

Sponsors & Collaborators

Principal Investigators

  • Jonah Hebert-Davies · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-08-01
Completion
2027-08-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06474949 on ClinicalTrials.gov